MedTrace Logo

AdheRence to Inhaled Corticosteroids in Asthma

NCT03769519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-12-17

Study results available
· View outcomes & findings →

Summary

It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adherence in adult African Americans.

Conditions

Interventions

BEHAVIORAL

ARICA

Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package.

Sponsors & Collaborators

Principal Investigators

  • Isaretta L Riley, MD · Duke Un.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-27
Primary Completion
2020-08-19
Completion
2020-08-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03769519 on ClinicalTrials.gov